CDC ENTEBBE

🇺🇬Uganda

Country: 🇺🇬Uganda

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI

Phase 2

Recruiting

Conditions: Latent Tuberculosis

Interventions: Drug: Rifapentine daily for 6 weeks
Drug: Rifapentine and Isoniazid weekly for 12 weeks
Drug: Rifampin and Isoniazid daily for 12 weeks
Drug: Rifampin daily for 16 weeks

First Posted Date: 2018-03-22

Last Posted Date: 2023-07-12

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 3400

Registration Number: NCT03474029

Locations: 🇦🇺
Liverpool Hospital, Sydney, Australia
🇺🇸
George Washington University, Washington, District of Columbia, United States
🇺🇸
New York City Bureau of TB Control, New York, New York, United States

and more 13 locations

HIV Prevention Among Latina Transgender Women Who Have Sex With Men: Evaluation of a Locally Developed Intervention

Not Applicable

Completed

Conditions: HIV Infections

Interventions: Behavioral: ChiCAS

First Posted Date: 2018-03-14

Last Posted Date: 2023-02-28

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 144

Registration Number: NCT03465852

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Iron Status of Women and Young Children in the United States

Completed

Conditions: Iron-deficiency
Nutritional Deficiency

First Posted Date: 2017-09-07

Last Posted Date: 2024-05-23

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 5000

Registration Number: NCT03274726

An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment

Not Applicable

Completed

Conditions: Tuberculosis
Drug-resistant Tuberculosis
Adherence, Medication
Adherence, Patient

Interventions: Other: Electronic DOT
Other: In-person DOT

First Posted Date: 2017-08-29

Last Posted Date: 2021-07-28

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 216

Registration Number: NCT03266003

Locations: 🇺🇸
Fort Greene Chest Center, Brooklyn, New York, United States
🇺🇸
Morrisania Chest Center, Bronx, New York, United States
🇺🇸
Corona Chest Center, Jackson Heights, New York, United States

and more 1 locations

Duration of IPV Priming and Antibody Decay

Phase 4

Completed

Conditions: Poliomyelitis

Interventions: Biological: Bivalent oral poliovirus vaccine (bOPV) at 6,10 and 14 weeks of age
Biological: Inactivated poliovirus vaccine (IPV) at 14 weeks and 9 months of age
Biological: Inactivated poliovirus vaccine (IPV) at 6 weeks and 9 months of age
Biological: Inactivated poliovirus vaccine (IPV) at 6 and 14 weeks of age
Biological: Inactivated poliovirus vaccine (IPV) at 14 weeks and 18 months of age
Biological: Inactivated poliovirus vaccine (IPV) at 14 weeks, 18 weeks and 18 months of age

First Posted Date: 2017-06-29

Last Posted Date: 2020-11-25

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 1645

Registration Number: NCT03202719

Locations: 🇧🇩
International Center for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh
🇧🇩
Mirpur clinic (International Center for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh

Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age

Phase 4

Completed

Conditions: Rubella Syndrome, Congenital
Measles
Rubella

Interventions: Biological: Measles-rubella (MR) vaccine at 9 months
Biological: Measles-rubella (MR) vaccine at 6 and 9 months

First Posted Date: 2017-03-07

Last Posted Date: 2020-12-30

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 620

Registration Number: NCT03071575

Locations: 🇧🇩
Icddr,B, Chāndpur, Bangladesh

JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo

Phase 3

Active, not recruiting

Conditions: Monkeypox Virus Infection

Interventions: Biological: JYNNEOS (Lyophilized Formulation)
Biological: JYNNEOS (Liquid Formulation)

First Posted Date: 2016-11-30

Last Posted Date: 2024-04-09

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 1600

Registration Number: NCT02977715

Locations: 🇨🇩
Tshuapa site, Boende, Tshuapa, Congo, The Democratic Republic of the

Fractional Inactivated Poliovirus Vaccine Booster and Rotavirus Study

Phase 4

Completed

Conditions: Poliomyelitis

Interventions: Biological: IPV at 14 and 22 weeks of age, RotaTeq
Biological: IPV at 6 and fIPV at 22 weeks, Rotarix
Biological: IPV at 6 and fIPV at 22 weeks, RotaTeq
Biological: IPV at 14 and 22 weeks of age, Rotarix
Biological: IPV at 14 and fIPV at 22 weeks, RotaTeq
Biological: IPV at 14 and fIPV at 22 weeks, Rotarix
Biological: fIPV at 6-14-22 weeks of age, Rotarix
Biological: fIPV at 6-14-22 weeks of age, RotaTeq

First Posted Date: 2016-07-27

Last Posted Date: 2018-07-18

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 1144

Registration Number: NCT02847026

Locations: 🇧🇩
International Center for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh

National Health and Nutrition Examination Survey 24-hour Urine Collection Feasibility Study, 2013

Completed

Conditions: Hypertension

First Posted Date: 2016-03-30

Last Posted Date: 2016-03-30

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 282

Registration Number: NCT02723682

Locations: 🇺🇸
National Health and Nutrition Examination Survey, Hyattsville, Maryland, United States

Cooperative Re-Engagement Controlled Trial (CoRECT)

Not Applicable

Completed

Conditions: Human Immunodeficiency Virus

Interventions: Other: Anti-Retroviral Treatment and Access to Services (ARTAS)

First Posted Date: 2016-02-26

Last Posted Date: 2021-02-21

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 1893

Registration Number: NCT02693145

Locations: 🇺🇸
Connecticut Department of Public Health, Hartford, Connecticut, United States
🇺🇸
Massachusetts Department of Public Health, Boston, Massachusetts, United States
🇺🇸
Philadelphia Department of Health, Philadelphia, Pennsylvania, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy